Literature DB >> 9273061

[Identification of the new protein kinase specifically transcribed in mouse tumors with high metastatic potential].

I V Korobko, A A Kabishev, S L Kiselev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9273061

Source DB:  PubMed          Journal:  Dokl Akad Nauk        ISSN： 0869-5652


× No keyword cloud information.
  6 in total

1.  Pro-survival activity of the MAK-V protein kinase in PC12 cells.

Authors:  Igor V Korobko; Svetlana V Kalinichenko; Elena V Korobko; Natalia N Ninkina; Sergey L Kiselev; Vladimir L Buchman
Journal:  Cell Cycle       Date:  2010-10-15       Impact factor: 4.534

2.  Metastasis-associated kinase modulates Wnt signaling to regulate brain patterning and morphogenesis.

Authors:  Alexey Kibardin; Olga Ossipova; Sergei Y Sokol
Journal:  Development       Date:  2006-06-21       Impact factor: 6.868

3.  The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis.

Authors:  Gerald B W Wertheim; Thomas W Yang; Tien-chi Pan; Anna Ramne; Zhandong Liu; Heather P Gardner; Katherine D Dugan; Petra Kristel; Bas Kreike; Marc J van de Vijver; Robert D Cardiff; Carol Reynolds; Lewis A Chodosh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-28       Impact factor: 11.205

4.  Cloning and developmental expression of MARK/Par-1/MELK-related protein kinase xMAK-V in Xenopus laevis.

Authors:  Alexey S Ruzov; Ilya B Mertsalov; Richard Meehan; Sergey L Kiselev; Vladimir L Buchman; Igor V Korobko
Journal:  Dev Genes Evol       Date:  2004-01-23       Impact factor: 0.900

5.  Hunk/Mak-v is a negative regulator of intestinal cell proliferation.

Authors:  Karen R Reed; Igor V Korobko; Natalia Ninkina; Elena V Korobko; Ben R Hopkins; James L Platt; Vladimir Buchman; Alan R Clarke
Journal:  BMC Cancer       Date:  2015-03-08       Impact factor: 4.430

6.  Identification of Nedd4 E3 ubiquitin ligase as a binding partner and regulator of MAK-V protein kinase.

Authors:  Svetlana V Kalinichenko; Keiji Itoh; Elena V Korobko; Sergei Y Sokol; Vladimir L Buchman; Igor V Korobko
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.